NEXCIDA THERAPEUTICS
Nexcida Therapeutics develops a novel antibiotics to treat serious, life-threatening bacterial infections. The company is led by an outstanding team of proven anti-infectives drug developers and is committed to addressing the emerging threat of drug-resistant bacteria. Nexcida Therapeutics was founded in 2014 and is based in Menlo Park, California.
NEXCIDA THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Life Science
Founded:
2014-01-01
Address:
Menlo Park, California, United States
Country:
United States
Status:
Active
Contact:
6503255156
Total Funding:
2.75 M USD
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Rebiotic Rx
Rebiotic Rx is develops novel liposomal antibiotics for antibiotic-resistant bacterial infections.
Trius Therapeutics
Trius Therapeutics is focused on the development of innovative antibiotics for life-threatening infections.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system